Apoptotic death of CD8+ T lymphocytes after immunization: Induction of a suppressive population of Mac-1+/Gr-1+ cells

Journal of Immunology

Volumn 161, Issue 10, 1998, Pages 5313-5320

  Bronte, Vincenzo ^a,d   Wang, Michael ^c   Overwijk, Willem W ^a   Surman, Deborah R ^a   Pericle, Federica ^b   Rosenberg, Steven A ^a   Restifo, Nicholas P ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d Department of Oncology and Surgical Sciences   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOREACTIVITY; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032533478     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Scott, D. W., Grdina T, and Shi Y. 1996. T cells commit suicide, but B cells are murdered! J. Immunol. 156:2352.
2. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
3. Critchfield, J. M., M. K. Racke, J. C. Zuniga-Pflucker, B. Cannella, C. S. Raine, J. Goverman, and M. J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139.
4. Welsh, R. M., L. K. Selin, and E. S. Razvi. 1995. Role of apoptosis in the regulation of virus-induced T cell responses, immune suppression, and memory. J. Cell. Biochem. 59:135.
5. Abbas, A. K. 1996. Die and let live: eliminating dangerous lymphocytes. Cell 84:655.
6. Van Parijs, L., and A. K. Abbas. 1996. Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8:321.
7. Wong, B., and Choi Y. 1997. Pathways leading to cell death in T cells. Curr. Opin. Immunol. 9:358.
8. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758.
9. Razvi, E. S., and R. M. Welsh. 1993. Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J. Virol. 67:5754.
10. Razvi, E. S., Z. Jiang, B. A. Woda, and R. M. Welsh. 1995. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am. J. Pathol. 147:79.
11. Young, M. R., M. A. Wright, Y. Lozano, J. P. Matthews, J. Benefield, and M. M. Prechel. 1996. Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int. J. Cancer 67:333.
12. Sulitzeanu, D. 1993. Immunosuppressive factors in human cancers. Adv. Cancer Res. 60:247.
13. Tsuchiya, Y., M. Igarashi, R. Suzuki, and K. Kumagai. 1988. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J. Immunol. 141:699.
14. Haskill, S., H. Koren, S. Becker, W. Fowler, and L. Walton. 1982. Mononuclear-cell infiltration in ovarian cancer. III. Suppressor-cell and ADCC activity of macrophages from ascitic and solid ovarian tumours. Br. J. Cancer 45:747.
15. Alleva, D. G., T. M. Walker, and K. D. Elgert. 1995. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-β 1: contrasting effects on resting and activated macrophages. J. Leukocyte Biol. 57:919.
16. Schleifer, K. W., and J. M. Mansfield. 1993. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151:5492.
17. al-Ramadi, B. K., M. A. Brodkin, D. M. Mosser, and T. K. Eisenstein. 1991. Immunosuppression induced by attenuated Salmonella: evidence for mediation by macrophage precursors. J. Immunol. 146:2737.
18. Bronte, V., K. Tsung, J. B. Rao, P. W. Chen, M. Wang, S. A. Rosenberg, and N. P. Restifo. 1995. IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. J. Immunol. 154: 5282.
19. Wang, M., V. Bronte, P. W. Chen, L. Gritz, D. Panicali, S. A. Rosenberg, and N. P. Restifo. 1995. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol. 154:4685.
20. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403.
21. Earl, P. L., and B. Moss. 1991. Generation of vaccinia viruses and their products. In Current Protocols in Molecular Biology. F. M. Ausubel, R. Kinston, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. Greene Publishing Associates and Wiley Interscience, New York, p. 16.18.1.
22. Smith, G. L., J. Z. Levin, P. Palese, and B. Moss. 1987. Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 160:336.
23. Whitman, E. D., K. Tsung, J. Paxson, and J. A. Norton. 1994. In vitro and in vivo kinetics of recombinant vaccinia virus cancer-gene therapy. Surgery 116:183.
24. Bronte, V., M. W. Carroll, T.J. Goletz, M. Wang, W. W. Overwijk, F. Marincola, S. A. Rosenberg, B. Moss, and N. P. Restifo. 1997. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc. Natl. Acad. Sci. USA 94:3183.
25. Gavin, M. A., M. J. Gilbert, S. R. Riddell, P. D. Greenberg, and M. J. Bevan. 1993. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol. 151:3971.
26. b-restricted CTL epitope of β-galactosidase: potential use in development of immunization protocols for "self" antigens. Methods 12:117.
27. Sherwood, S. W., and R. T. Schimke. 1995. Cell cycle analysis of apoptosis using flow cytometry. Methods Cell Biol. 46:77.
28. Wang, M., P. W. Chen, V. Bronte, Y. Zhai, S. A. Rosenberg, and N. P. Restifo. 1995. Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor antigen. J. Immunother. 18:139.
29. Hestdal, K., F. W. Ruscetti, J. N. Ihle, S. E. Jacobsen, C. M. Dubois, W. C. Kopp, D. L. Longo, and J. R. Keller. 1991. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147:22.
30. Saron, M. F., B. Shidani, M. A. Nahori, J. C. Guillon, and P. Truffa-Bachi. 1990. Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes. J. Virol. 64:4076.
31. Selin, L. K., S. R. Nahill, and R. M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179: 1933.
32. Zarozinski, C. C., and R. M. Welsh. 1997. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J. Exp. Med. 185: 1629.
33. Ehl, S., J. Hombach, P. Aichele, H. Hengartner, and R. M. Zinkernagel. 1997. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J. Exp. Med. 185:1241.
34. Butz, E. A., and M. J. Bevan. 1998. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8:167.
35. McMichael, A., and C. A. O'Callaghan. 1998. A new look at T cells. J. Exp. Med. 187:1367.
36. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569.
37. Matiba, B., S. M. Mariani, and P. H. Krammer. 1997. The CD95 system and the death of a lymphocyte. Semin. Immunol. 9:59.
38. Owen-Schaub, L. B., S. Yonehara, W. L. Crump, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol. 140:197.
39. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
40. Sneller, M. C., J. Wang, J. K. Dale, W. Stroher, L. A. Middelton, Y. Choi, T. A. Fleisher, M. S. Lim, E. S. Jaffe, J. M. Puck, M. J. Lenardo, and S. E. Straus. 1997. Clincial, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89:1341.
41. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middleton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
42. Lohman, B. L., Razvi, E. S., and Welsh, R. M. 1996. T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J. Virol. 70:8199.
43. Strober, S. 1984. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu. Rev. Immunol. 2:219.
44. Oseroff, A., S. Okada, and S. Strober. 1984. Natural suppressor (NS) cells found in the spleen of neonatal mice and adult mice given total lymphoid irradiation (TLI) express the null surface phenotype. J. Immunol. 132:101.
45. Maier, T., J. H. Holda, and H. N. Claman. 1985. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity. J. Immunol. 135:1644.
46. Jaffe, M. L., H. Arai, and G. J. Nabel. 1996. Mechanisms of tumor-induced immunosuppression: evidence for contact-dependent T cell suppression by monocytes. Mol. Med. 2:692.
47. Rosenberg, S. A., J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola, Topalian S. L., Restifo N. P., M. E. Dudley, Schwarz S. L., P. J. Spiess, J. R. Wunderlich, M. R. Parkhurst, Y. Kawakami, C. A. Seipp, J. H. Einhorn, and D. E. White. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321.